Houston, TX, United States of America

Robert J Schwartz

USPTO Granted Patents = 25 

 

 

Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 370(Granted Patents)


Company Filing History:


Years Active: 1987-2024

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):

Title: The Innovative Work of Inventor Robert J Schwartz

Introduction:

Robert J Schwartz is a prolific inventor based in Houston, Texas, with a remarkable portfolio of 24 patents to his name. His groundbreaking research in the field of cardiomyocyte regeneration and the utilization of ROCK inhibitors has significantly advanced the medical field.

Latest Patents:

One of Schwartz's latest patents involves enhanced cardiomyocyte regeneration, where he developed compositions and methods to promote adult mammalian cardiomyocyte processes. By locally administering therapeutic agents containing modified messenger RNA, Schwartz aims to express mutated serum response factor and YAP polypeptides to stimulate cardiomyocyte proliferation and cardiac regeneration.

Another notable patent of Schwartz is the development of ROCK inhibitors for treating various disorders, including heart failure. His work on peptide inhibitors of Rho-associated-kinase, inhibiting ROCK1 activity and identifying novel inhibitory drugs, has promising implications for treating heart disease, pulmonary hypertension, glaucoma, and other critical conditions.

Career Highlights:

Robert J Schwartz's illustrious career includes significant contributions to Baylor College of Medicine and other prestigious institutions. His innovative research has garnered attention for its potential to revolutionize treatment approaches in cardiovascular and related diseases.

Collaborations:

Throughout his career, Schwartz has collaborated with leading experts in the field, including Ruxandra Draghia-Akli and Franco J DeMayo. These partnerships have further enriched his research endeavors and propelled his inventions to new heights.

Conclusion:

Inventor Robert J Schwartz's pioneering work in cardiomyocyte regeneration and ROCK inhibitors underscores his commitment to advancing medical science. With a track record of innovative patents and fruitful collaborations, Schwartz continues to make valuable contributions to the healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…